Tianxiao Wu

645 citations

35 papers · 510 indexed · h-index 16

Co-authors: Dongmei Zhao Maosheng Cheng Wenbo Yin Yixiang Sun Chenzhou Hao Yin Sun Sijia Yu Xinran Wang
Topics: Melanoma and MAPK Pathways (8 papers)Quinazolinone synthesis and applications (6 papers)Protein Kinase Regulation and GTPase Signaling (6 papers)
Cited by: Immunology and Allergy Organic Chemistry Oncology
Journals: Journal of Medicinal Chemistry Molecules Organic Letters
Partner nations: China

In The Last Decade

Tianxiao Wu

35 papers receiving 505 citations

Peers

Countries citing papers authored by Tianxiao Wu

Since Specialization

Citations

This map shows the geographic impact of Tianxiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxiao Wu more than expected).

Fields of papers citing papers by Tianxiao Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxiao Wu. The network helps show where Tianxiao Wu may publish in the future.

Co-authorship network of co-authors of Tianxiao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxiao Wu. A scholar is included among the top collaborators of Tianxiao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxiao Wu. Tianxiao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Super-resolution microscopy reveals new insights into organelle interactions 2024 ·(unknown),(unknown),Xiao‐Shun Zhou,Tianxiao Wu,Jiaming Qian,Shijia Wu,Yongtao Liu,Chao Zuo	1
2	Discovery of novel indazole derivatives as second-generation TRK inhibitors 2024 ·European Journal of Medicinal Chemistry ·(unknown),Shuyu Lu,Zhiqiang Guo,Zhuo Li,(unknown),Xin Wang,Tianxiao Wu,Yixiang Sun,Nian Liu,Haoyu Zhang,Dongmei Zhao,Maosheng Cheng	5
3	Design, synthesis and biological evaluation of novel indolin-2-one derivatives as potent second-generation TRKs inhibitors 2023 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Xin Wang,Ruicheng Lv,Shuyu Lu,Zhiqiang Guo,Tianxiao Wu,Yin Sun,Yixiang Sun,Nian Liu,Dongmei Zhao,Maosheng Cheng	7
4	Discovery of novel 3-(1H-pyrazol-4-yl)-1H-indazole derivatives as potent type II TRK inhibitors against acquired resistance 2023 ·European Journal of Medicinal Chemistry ·(unknown),Zhiqiang Guo,Shuyu Lu,Xin Wang,(unknown),Tianxiao Wu,Yixiang Sun,Nian Liu,Haoyu Zhang,Dongmei Zhao,Maosheng Cheng	4
5	Design, synthesis, and biological evaluation of diaminopyrimidine derivatives as novel focal adhesion kinase inhibitors 2023 ·RSC Medicinal Chemistry ·Yixiang Sun,Zixuan Gao,Ruifeng Wang,Guoqi Zhang,Tianxiao Wu,Wenbo Yin,Yin Sun,(unknown),Dongmei Zhao,Maosheng Cheng	1
6	Discovery of quinazoline derivatives CZw-124 as a pan-TRK inhibitor with potent anticancer effects in vitro and in vivo 2022 ·European Journal of Medicinal Chemistry ·Tianxiao Wu,(unknown),Ruicheng Lv,Nian Liu,Wenbo Yin,Chenzhou Hao,Yin Sun,Chu Zhang,Yixiang Sun,Dongmei Zhao,Maosheng Cheng	18
7	Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer 2022 ·European Journal of Medicinal Chemistry ·Yin Sun,(unknown),(unknown),Tianxiao Wu,Wenbo Yin,Jingkai Wang,(unknown),(unknown),Yixiang Sun,Huali Yang,Dongmei Zhao,Maosheng Cheng	16
8	Identification of novel indole derivatives as highly potent and efficacious LSD1 inhibitors 2022 ·European Journal of Medicinal Chemistry ·Xiangyu Zhang,Yixiang Sun,Hai‐Lan Huang,Xinran Wang,Tianxiao Wu,Wenbo Yin,Xiaojia Li,Lin Wang,(unknown),Dongmei Zhao,Maosheng Cheng	15
9	Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor 2022 ·European Journal of Medicinal Chemistry ·Yin Sun,Lin Wang,(unknown),Jingkai Wang,(unknown),Tianxiao Wu,Wenbo Yin,(unknown),Yixiang Sun,(unknown),(unknown),(unknown),Dongmei Zhao,Maosheng Cheng	10
10	Therapeutic potential of targeting LSD1/ KDM1A in cancers 2021 ·Pharmacological Research ·Xiangyu Zhang,Xinran Wang,Tianxiao Wu,Wenbo Yin,(unknown),Yixiang Sun,Dongmei Zhao	36
11	Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors 2021 ·European Journal of Medicinal Chemistry ·Xiangyu Zhang,Hai‐Lan Huang,Ziheng Zhang,(unknown),Tianxiao Wu,Wenbo Yin,Yixiang Sun,Xinran Wang,(unknown),Dongmei Zhao,Maosheng Cheng	29
12	Design, synthesis, biological evaluation and pharmacophore model analysis of novel tetrahydropyrrolo[3,4-c]pyrazol derivatives as potential TRKs inhibitors 2021 ·European Journal of Medicinal Chemistry ·Tianxiao Wu,Chu Zhang,Ruicheng Lv,(unknown),Nian Liu,Wenbo Yin,Ruifeng Wang,Yin Sun,Xiaoyan Wang,Yixiang Sun,Dongmei Zhao,Maosheng Cheng	16
13	Broadening antifungal spectrum and improving metabolic stablity based on a scaffold strategy: Design, synthesis, and evaluation of novel 4-phenyl-4,5-dihydrooxazole derivatives as potent fungistatic and fungicidal reagents 2021 ·European Journal of Medicinal Chemistry ·Wenbo Yin,(unknown),Hong Jiang,(unknown),Lei Liu,Tianxiao Wu,Yin Sun,Liyu Zhao,Xin Su,Dongmei Zhao,Maosheng Cheng	7
14	Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study 2020 ·Bioorganic Chemistry ·Ruifeng Wang,(unknown),Sijia Yu,Yixuan Chen,(unknown),Tianxiao Wu,Chenzhou Hao,Dongmei Zhao,Maosheng Cheng	24
15	Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents 2019 ·European Journal of Medicinal Chemistry ·Ruifeng Wang,Yixuan Chen,(unknown),Sijia Yu,Bowen Yang,Tianxiao Wu,Jing Guo,Chenzhou Hao,Dongmei Zhao,Maosheng Cheng	35
16	Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors 2019 ·European Journal of Medicinal Chemistry ·Ruifeng Wang,Sijia Yu,(unknown),Yixuan Chen,Bowen Yang,Tianxiao Wu,Chenzhou Hao,Dongmei Zhao,Maosheng Cheng	47
17	An Acid-Catalyzed Epoxide Ring-Opening/Transesterification Cascade Cyclization to Diastereoselective Syntheses of (±)-β-Noscapine and (±)-β-Hydrastine 2019 ·Organic Letters ·Jihui Li,Yongxiang Liu,(unknown),Tianxiao Wu,(unknown),Yang Zheng,(unknown),Dongmei Zhao,Maosheng Cheng	10
18	Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor 2019 ·European Journal of Medicinal Chemistry ·Jing Guo,Tingting Wang,Tianxiao Wu,Kehan Zhang,Wenbo Yin,Mingyue Zhu,(unknown),Chenzhou Hao,Zhonggui He,Maosheng Cheng,Yang Liu,Jiang Zheng,Jingkai Gu,Dongmei Zhao	12
19	Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors 2018 ·European Journal of Medicinal Chemistry ·Jing Guo,(unknown),Wenbo Yin,Mingyue Zhu,Chenzhou Hao,(unknown),Tianxiao Wu,Jian Wang,Dongmei Zhao,Haitao Li,Maosheng Cheng	26
20	Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study 2017 ·Bioorganic & Medicinal Chemistry ·Jing Guo,Mingyue Zhu,Tianxiao Wu,Chenzhou Hao,Kai Wang,(unknown),Wanxu Huang,Jian Wang,Dongmei Zhao,Maosheng Cheng	30

About Tianxiao Wu

Tianxiao Wu is a scholar working on Structural Biology, Immunology and Allergy and Oncology, having authored 35 papers that have together received 510 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (8 papers), Quinazolinone synthesis and applications (6 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). The work is most often cited by research in Immunology and Allergy (64 citations), Organic Chemistry (198 citations) and Oncology (133 citations). Tianxiao Wu has collaborated with scholars based in China. Frequent co-authors include Dongmei Zhao, Maosheng Cheng, Wenbo Yin, Yixiang Sun, Chenzhou Hao, Yin Sun, Sijia Yu, Xinran Wang, Jing Guo and Xiangyu Zhang. Their work appears in journals such as Journal of Medicinal Chemistry, Molecules and Organic Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact